Testing the effectiveness of belumosudil for bilateral lung transplant patients
The purpose of this study is to help the study sponsor determine whether adding the study drug, belumosudil, to usual treatment (immunosuppression per transplant site and azithromycin) is better, the same or worse than the usual treatment approach alone for chronic lung rejection.